CN102827068A - 一种4-(2, 3-二氯苯基)-2, 6-二甲基-1, 4-二氢-5-甲氧基羰基-3-吡啶羧酸的制备方法 - Google Patents
一种4-(2, 3-二氯苯基)-2, 6-二甲基-1, 4-二氢-5-甲氧基羰基-3-吡啶羧酸的制备方法 Download PDFInfo
- Publication number
- CN102827068A CN102827068A CN2011101653425A CN201110165342A CN102827068A CN 102827068 A CN102827068 A CN 102827068A CN 2011101653425 A CN2011101653425 A CN 2011101653425A CN 201110165342 A CN201110165342 A CN 201110165342A CN 102827068 A CN102827068 A CN 102827068A
- Authority
- CN
- China
- Prior art keywords
- dimethyl
- dichlorophenyl
- dihydro
- reaction
- tert
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title abstract description 8
- LHAOQTPGTBGTIG-UHFFFAOYSA-N 4-(2,3-dichlorophenyl)-5-methoxycarbonyl-2,6-dimethyl-1,4-dihydropyridine-3-carboxylic acid Chemical compound COC(=O)C1=C(C)NC(C)=C(C(O)=O)C1C1=CC=CC(Cl)=C1Cl LHAOQTPGTBGTIG-UHFFFAOYSA-N 0.000 title abstract 4
- 238000000034 method Methods 0.000 claims abstract description 17
- 238000006243 chemical reaction Methods 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 11
- -1 vinyl acetate-beta propyl ester Chemical compound 0.000 claims abstract description 8
- 238000005580 one pot reaction Methods 0.000 claims abstract description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims abstract description 5
- 230000005494 condensation Effects 0.000 claims abstract description 4
- 150000002148 esters Chemical class 0.000 claims abstract description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 20
- 150000004702 methyl esters Chemical class 0.000 claims description 14
- 229960003512 nicotinic acid Drugs 0.000 claims description 14
- 239000011664 nicotinic acid Substances 0.000 claims description 14
- 239000002253 acid Substances 0.000 claims description 10
- XDNHONSQWPVCOY-UHFFFAOYSA-N C(C)(=O)OC(C)C.C=C Chemical compound C(C)(=O)OC(C)C.C=C XDNHONSQWPVCOY-UHFFFAOYSA-N 0.000 claims description 8
- LLMLNAVBOAMOEE-UHFFFAOYSA-N 2,3-dichlorobenzaldehyde Chemical compound ClC1=CC=CC(C=O)=C1Cl LLMLNAVBOAMOEE-UHFFFAOYSA-N 0.000 claims description 7
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- 239000000047 product Substances 0.000 claims description 7
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 6
- KPBZROQVTHLCDU-GOSISDBHSA-N clevidipine Chemical compound CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)[C@H]1C1=CC=CC(Cl)=C1Cl KPBZROQVTHLCDU-GOSISDBHSA-N 0.000 claims description 6
- 229960003597 clevidipine Drugs 0.000 claims description 6
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 claims description 6
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 claims description 5
- 239000007795 chemical reaction product Substances 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 4
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 claims description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 4
- PYOKUURKVVELLB-UHFFFAOYSA-N trimethyl orthoformate Chemical compound COC(OC)OC PYOKUURKVVELLB-UHFFFAOYSA-N 0.000 claims description 4
- 229960000549 4-dimethylaminophenol Drugs 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 3
- 230000000996 additive effect Effects 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 238000009833 condensation Methods 0.000 claims description 3
- 125000004122 cyclic group Chemical group 0.000 claims description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 2
- 125000005233 alkylalcohol group Chemical group 0.000 claims description 2
- QVQGTNFYPJQJNM-UHFFFAOYSA-N dicyclohexylmethanamine Chemical compound C1CCCCC1C(N)C1CCCCC1 QVQGTNFYPJQJNM-UHFFFAOYSA-N 0.000 claims description 2
- 229940043279 diisopropylamine Drugs 0.000 claims description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 claims description 2
- 239000002808 molecular sieve Substances 0.000 claims description 2
- 229960005181 morphine Drugs 0.000 claims description 2
- 150000003053 piperidines Chemical class 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- 150000003233 pyrroles Chemical class 0.000 claims description 2
- 239000000376 reactant Substances 0.000 claims description 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 claims description 2
- 150000007530 organic bases Chemical class 0.000 claims 1
- 238000006482 condensation reaction Methods 0.000 abstract description 5
- 230000002378 acidificating effect Effects 0.000 abstract description 4
- 238000000746 purification Methods 0.000 abstract description 3
- 238000007363 ring formation reaction Methods 0.000 abstract description 3
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 abstract 3
- RHKTVCLHLVHXOA-UHFFFAOYSA-N 1,2-dichlorobenzene formaldehyde Chemical compound C=O.ClC1=CC=CC=C1Cl RHKTVCLHLVHXOA-UHFFFAOYSA-N 0.000 abstract 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
- 229920002554 vinyl polymer Polymers 0.000 abstract 1
- 238000003756 stirring Methods 0.000 description 6
- 0 *C(c1cccc(Cl)c1Cl)=O Chemical compound *C(c1cccc(Cl)c1Cl)=O 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- KPBZROQVTHLCDU-UHFFFAOYSA-N clevidipine Chemical compound CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC(Cl)=C1Cl KPBZROQVTHLCDU-UHFFFAOYSA-N 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 238000002953 preparative HPLC Methods 0.000 description 2
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical compound C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 description 1
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- CDVCVNPWNZVFOI-FNORWQNLSA-N CCC(/C=C(\C)/N)=C Chemical compound CCC(/C=C(\C)/N)=C CDVCVNPWNZVFOI-FNORWQNLSA-N 0.000 description 1
- 108090000312 Calcium Channels Proteins 0.000 description 1
- 102000003922 Calcium Channels Human genes 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 238000003445 Hantzsch reaction Methods 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- WRQNANDWMGAFTP-UHFFFAOYSA-N Methylacetoacetic acid Chemical compound COC(=O)CC(C)=O WRQNANDWMGAFTP-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 229960003621 clevidipine butyrate Drugs 0.000 description 1
- 229940010811 cleviprex Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- OJURWUUOVGOHJZ-UHFFFAOYSA-N methyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-(2-methoxy-2-oxoethyl)amino]ethyl]amino]acetate Chemical compound C=1C=CC=C(OC(C)=O)C=1CN(CC(=O)OC)CCN(CC(=O)OC)CC1=CC=CC=C1OC(C)=O OJURWUUOVGOHJZ-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 210000002464 muscle smooth vascular Anatomy 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Pyridine Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101653425A CN102827068A (zh) | 2011-06-17 | 2011-06-17 | 一种4-(2, 3-二氯苯基)-2, 6-二甲基-1, 4-二氢-5-甲氧基羰基-3-吡啶羧酸的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101653425A CN102827068A (zh) | 2011-06-17 | 2011-06-17 | 一种4-(2, 3-二氯苯基)-2, 6-二甲基-1, 4-二氢-5-甲氧基羰基-3-吡啶羧酸的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102827068A true CN102827068A (zh) | 2012-12-19 |
Family
ID=47330410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011101653425A Pending CN102827068A (zh) | 2011-06-17 | 2011-06-17 | 一种4-(2, 3-二氯苯基)-2, 6-二甲基-1, 4-二氢-5-甲氧基羰基-3-吡啶羧酸的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102827068A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103086956A (zh) * | 2013-01-17 | 2013-05-08 | 北京嘉林药业股份有限公司 | 一种丁酸氯维地平中间体的纯化方法 |
CN104557679A (zh) * | 2013-10-23 | 2015-04-29 | 丹阳恒安化学科技研究所有限公司 | 一种西尼地平的合成方法 |
CN104557678A (zh) * | 2013-10-23 | 2015-04-29 | 丹阳恒安化学科技研究所有限公司 | 一种制备阿雷地平的方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0007293A1 (en) * | 1978-06-30 | 1980-01-23 | Aktiebolaget Hässle | 2,6-Dimethyl-4-(2,3-dichlorophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid-3-methyl ester-5-ethyl ester having hypotensive properties, process for its preparation and pharmaceutical preparations containing it |
WO2000031035A1 (en) * | 1998-11-23 | 2000-06-02 | Astrazeneca Ab | New manufacturing process |
CN101759631A (zh) * | 2009-12-29 | 2010-06-30 | 中山大学 | 一种丁酸氯维地平的制备方法 |
-
2011
- 2011-06-17 CN CN2011101653425A patent/CN102827068A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0007293A1 (en) * | 1978-06-30 | 1980-01-23 | Aktiebolaget Hässle | 2,6-Dimethyl-4-(2,3-dichlorophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid-3-methyl ester-5-ethyl ester having hypotensive properties, process for its preparation and pharmaceutical preparations containing it |
WO2000031035A1 (en) * | 1998-11-23 | 2000-06-02 | Astrazeneca Ab | New manufacturing process |
CN101759631A (zh) * | 2009-12-29 | 2010-06-30 | 中山大学 | 一种丁酸氯维地平的制备方法 |
Non-Patent Citations (3)
Title |
---|
K. GORLITZER,等: ""Strategien zur Syntheses Nifedipin-analoger Ester von L-Ascorbinsaure"", 《PHARMAZIE》 * |
RANDY W. JACKSON: "A mild and selective method for the cleavage of tert-butyl esters", 《TETRAHEDRON LETTERS》 * |
胡春,等: "4-(2-呋喃基)-2-氧代四氢嘧啶-5-羧酸酯的合成及其钙拮抗活性", 《中国药物化学杂志》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103086956A (zh) * | 2013-01-17 | 2013-05-08 | 北京嘉林药业股份有限公司 | 一种丁酸氯维地平中间体的纯化方法 |
CN103086956B (zh) * | 2013-01-17 | 2015-11-04 | 北京嘉林药业股份有限公司 | 一种丁酸氯维地平中间体的纯化方法 |
CN104557679A (zh) * | 2013-10-23 | 2015-04-29 | 丹阳恒安化学科技研究所有限公司 | 一种西尼地平的合成方法 |
CN104557678A (zh) * | 2013-10-23 | 2015-04-29 | 丹阳恒安化学科技研究所有限公司 | 一种制备阿雷地平的方法 |
CN104557678B (zh) * | 2013-10-23 | 2017-05-17 | 丹阳恒安化学科技研究所有限公司 | 一种制备阿雷地平的方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102827068A (zh) | 一种4-(2, 3-二氯苯基)-2, 6-二甲基-1, 4-二氢-5-甲氧基羰基-3-吡啶羧酸的制备方法 | |
CN101316820A (zh) | 制备手性氨氯地平龙胆酸盐的方法 | |
JP2015500325A5 (zh) | ||
CN102367236A (zh) | 一种盐酸多奈哌齐的合成工艺 | |
CN1105104C (zh) | 新的制备方法 | |
CN105315256A (zh) | 一种适合工业化的高纯度琥珀酸曲格列汀的制备方法 | |
JP4871130B2 (ja) | メソトリオンを精製する方法 | |
CN108409589B (zh) | 一种带手性的β-氨基酸酯的制备方法 | |
WO2011117876A1 (en) | An improved process for the preparation of amlodipine free base and acid addition salts thereof | |
CN106496099B (zh) | 2-[(2r,6s)-6-[(2s)-2-羟基-2-苯乙基]-1-甲基哌啶]-1-苯乙酮的合成方法 | |
CN104016954A (zh) | 奈必洛尔中间体的制备及纯化方法 | |
CN114014863A (zh) | 骨髓保护剂曲拉西利的制备方法 | |
WO2012069989A1 (en) | Process for preparation of clevidipine and its intermediate | |
RU2707043C1 (ru) | Способ получения гербицида имазамокса | |
WO2011127599A1 (en) | Preparation of clevidipine butyrate | |
JP5463051B2 (ja) | 1,4―ジヒドロピリジン誘導体の製造法 | |
CN114349693B (zh) | 一种度鲁特韦关键中间体的制备方法 | |
CN111320622A (zh) | 一种莫西沙星盐酸盐的合成方法 | |
CN103012264A (zh) | 3-取代氨基-六氢-1h-氮杂环庚烷的拆分方法 | |
WO2011130852A1 (en) | Preparation of intermediates for the synthesis of dihydropyridine calcium channel blockers | |
CN100408577C (zh) | 咪唑并(1,2-a)吡啶-3-乙酰胺类的制备方法 | |
CN101646675A (zh) | 季n-烷基吗啡喃生物碱盐的制备方法 | |
WO2004002958A1 (en) | Industrial process for the synthesis of isobutyl methyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridine dicarboxylate (nisoldipine) | |
RU2414452C1 (ru) | Способ одновременного получения 2-нитро-5-хлоранилина и 2-нитро-4-хлоранилина | |
EP3404019B1 (en) | Process for the preparation of high purity miglustat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI FUQI MEDICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: ZHANG RUIHAO Effective date: 20131016 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Tan Junde Inventor after: Wang Lei Inventor before: Zhang Ruihao Inventor before: Chang Ying Inventor before: Lu Feng |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHANG RUIHAO CHANG YING LU FENG TO: TAN JUNDE WANG LEI Free format text: CORRECT: ADDRESS; FROM: 201103 MINHANG, SHANGHAI TO: 201210 PUDONG NEW AREA, SHANGHAI |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20131016 Address after: 201210 Shanghai Zhangjiang High Tech Park of Pudong New Area Cailun Road No. 1 Building No. 416 room 720 Applicant after: Shanghai wonder Pharmaceutical Technology Co Ltd Address before: 201103, 460, Lane 202, Rainbow Road, Hongqiao Town, Shanghai, Minhang District, room 5 Applicant before: Zhang Ruihao |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C05 | Deemed withdrawal (patent law before 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20121219 |